G

GemVax & KAEL Co Ltd
KOSDAQ:082270

Watchlist Manager
GemVax & KAEL Co Ltd
KOSDAQ:082270
Watchlist
Price: 35 500 KRW 7.58% Market Closed
Market Cap: 1.5T KRW

Intrinsic Value

The intrinsic value of one GemVax & KAEL Co Ltd stock under the Base Case scenario is 2 597.99 KRW. Compared to the current market price of 35 500 KRW, GemVax & KAEL Co Ltd is Overvalued by 93%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 597.99 KRW
Overvaluation 93%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
GemVax & KAEL Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GemVax & KAEL Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GemVax & KAEL Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

GemVax & KAEL Co Ltd
KOSDAQ:082270
KR
Semiconductors
Market Cap
1.4T KRW
IPO
Jun 24, 2005
KR
Semiconductors
Market Cap
1.4T KRW
IPO
Jun 24, 2005
Price
â‚©false
EPS
â‚©false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about GemVax & KAEL Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
GemVax & KAEL Co Ltd

Current Assets 25.2B
Cash & Short-Term Investments 3.6B
Receivables 11.1B
Other Current Assets 10.5B
Non-Current Assets 125.6B
Long-Term Investments 55.3B
PP&E 36.6B
Intangibles 3.3B
Other Non-Current Assets 30.4B
Efficiency

Free Cash Flow Analysis
GemVax & KAEL Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
GemVax & KAEL Co Ltd

Revenue
62.7B KRW
Cost of Revenue
-43B KRW
Gross Profit
19.7B KRW
Operating Expenses
-58.1B KRW
Operating Income
-38.3B KRW
Other Expenses
-48.9B KRW
Net Income
-87.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

GemVax & KAEL Co Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROE
19/100
Profitability
Score

GemVax & KAEL Co Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

GemVax & KAEL Co Ltd's solvency score is 18/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Positive Net Debt
18/100
Solvency
Score

GemVax & KAEL Co Ltd's solvency score is 18/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
GemVax & KAEL Co Ltd

There are no price targets for GemVax & KAEL Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GemVax & KAEL Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one GemVax & KAEL Co Ltd stock?

The intrinsic value of one GemVax & KAEL Co Ltd stock under the Base Case scenario is 2 597.99 KRW.

Is GemVax & KAEL Co Ltd stock undervalued or overvalued?

Compared to the current market price of 35 500 KRW, GemVax & KAEL Co Ltd is Overvalued by 93%.

Back to Top